Bone Biologics (BBLGW) Other financing activities (2013 - 2024)
Bone Biologics' (BBLGW) quarterly Other financing activities came in at $287233.0 in Q3 2024, down 77.02% quarter-over-quarter from $1.2 million in Q1 2016.
Powered by 
Analysis
Bone Biologics (BBLGW) Other financing activities (2013 - 2024) Analysis & Trends
Bone Biologics (BBLGW) has reported Other financing activities for 3 consecutive years, with $287233.0 the latest figure, recorded in Q3 2024.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $287233.0 in Q3 2024; TTM through Dec 2024 was $287233.0, a N/A change from a year earlier, with the FY2024 full-year figure at $662.0, changed N/A from the prior year.
- Other financing activities was $287233.0 for Q3 2024 at Bone Biologics, down from $1.2 million in the prior quarter.
- Over five years, Other financing activities peaked at $287233.0 in Q3 2024 and troughed at $287233.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Bone Biologics | 9.52 Mn | 9.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 287,233.00 |
| Mar 31, 2016 | 1.25 Mn |
| Jul 31, 2013 | 4,994.00 |